Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?-Reference-Cited by-同舟云学术

Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?

Published:2015-12-21 Issue:12 Volume:10 Page:e0145463
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jwa Eunjin,Shin Kyung Hwan,Lim Hyeon Woo,Jung So-Youn,Lee Seeyoun,Kang Han-Sung,Lee EunSook,Park Young Hee

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Breast Cancer Version 2.2015;WJ Gradishar;J Natl Compr Canc Netw,2015

2. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology;A Recht;J Clin Oncol,2001

3. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007;A Goldhirsch;Ann Oncol,2007

4. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial;M Overgaard;N Engl J Med,1997

5. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial;M Overgaard;Lancet,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach;Annals of Surgical Oncology;2023-12-23

2. Developing prompts from large language model for extracting clinical information from pathology and ultrasound reports in breast cancer;Radiation Oncology Journal;2023-09-30

3. Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy;Frontiers in Oncology;2023-03-28

4. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer;BMC Cancer;2022-12-27

5. Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated;Breast Cancer Research and Treatment;2021-04-27